In contrast, FOXO6 promotes gastric cancer cell proliferation through cMyc induction (Qinyu et al., 2013), and its loss inhibits colorectal cancer cell proliferation, invasion and glycolysis, with decreased PI3K/AKT/mTOR pathway activation (Li et al., 2019). The gene discussed is MYC; the disease is gastric cancer.